TABLE 3.

Recurrent biliary obstructions and adverse events (n = 46)

RBO on ITT analysis, n (%)	15 (32.6)
Causes of RBO
Stent ingrowth, n (%)	14 (30.4)
Stent overgrowth, n (%)	1 (2.2)
RBO on PP analysis, n (%)	14/43 (32.6)
Causes of RBO
Stent ingrowth, n (%)	13/43 (30.2)
Stent overgrowth, n (%)	1/43 (2.3)
Early adverse events on ITT analysis, n (%)	2 (4.3)
Pancreatitis, n (%)	2 (4.3)
Late adverse events on ITT analysis, n (%)	0 (0)
Late adverse events on PP analysis, n (%)	0/43 (0)

Abbreviations: ITT, intention‐to‐treat; PP, per‐protocol; RBO, recurrent biliary obstruction.